Connect with us

Health

Kenyan doctor condemns WHO for sterilizing African women with vaccines

Published

6 minute read

Dr. Wahome Ngare

From LifeSiteNews

By Emily Mangiaracina

In 2014 and 2015, the WHO campaigned for the eradication of Tetanus in Africa, pushing a vaccine that, according to Dr. Ngare, made women “sterile.”

A Kenyan doctor denounced the World Health Organization (WHO) before Uganda’s president for being untrustworthy as shown by its African vaccination campaigns, including a Tetanus shot push that caused infertility in women.

Dr. Wahome Ngare, the director of Kenya Christian Professionals Forum (KCPF), warned President Yoweri Museveni in a speech posted online Tuesday, as the WHO was negotiating amendments to the International Health Regulations (IHR), that the massively influential global health body has a recent history of working against the best interests of Africans.

As a glaring example of this, he told how in 2014 and 2015, the WHO campaigned for the eradication of Tetanus in Africa, pushing a vaccine that, according to Dr. Ngare, made women “sterile.” He explained that the vaccine combined the Tetanus virus with a substance that produces antibodies against a hormone needed to maintain pregnancy, called human chorionic gonadotropin (hCG).

“When we inject a woman with that vaccine, she produces antibodies against that hormone and therefore is rendered sterile,” Dr. Ngare noted. A paper has been published in the journal Vaccine Weekly echoing the Kenyan doctor’s claim, asserting that “similar tetanus vaccines laced with hCG” (to produce antibodies against the natural hormone) “have been uncovered in the Philippines and in Nicaragua.”

The article’s abstract pointed out that a former president of Human Life International (HLI) “asked Congress to investigate reports of women in some developing countries unknowingly receiving a tetanus vaccine laced with the anti-fertility drug.”

Dr. Ngare said he and other doctors in Africa have noticed increasing cases of young couples who appear medically “normal” but cannot conceive children, as well as couples who are losing as many as “three, four, or five” children before the mother can carry a child to term.

He went on to argue that another reason the WHO cannot be trusted is that it has proposed the vaccination of African children against malaria despite the fact that it is a “treatable disease.”

He pointed out that the U.K. “was able to eradicate malaria in 1921,” and the U.S. eliminated the disease in 1951, but the WHO has seemingly not yet worked out how to rid the African continent of malaria. Dr. Ngare argued that in fact, there is a natural treatment for malaria, found in the trees used to create quinine, which is known to treat malaria. There is further a plant, known as Artemisia annua or sweet wormwood plant, grown in Africa, that also treats malaria.

“One of our doctors in Congo wrote a paper that demonstrated how well the Artemisia tea worked and compared it to conventional medicine and even demonstrated it works better than conventional medicine. And two years later, his paper was pulled out. It was retracted. We do not need a vaccine for our children to treat malaria,” Dr. Ngare told Museveni.

Dr. Ngare has previously advised African countries to “collectively treat all vaccination programs as a national security risk,” stating, “If you cannot determine what is in the vaccine that is being given to your people, you may be opening a door to destroy the African population.”

The WHO has been under heavy fire recently from politicians and activists around the world for its proposed “pandemic agreement” and amendments to the International Health Regulations (IHR), on which the WHO failed to gain consensus from its member states this week. A more modest “consensus package of (IHR) amendments” will be presented this week, and The New York Times reported that negotiators plan to ask for more time to come to an agreement.

WHO Director-General Tedros Adhanom Ghebreyesus has also suggested that efforts to come to an agreement on the proposals will continue.

“We all wish that we had been able to reach a consensus on the agreement in time for this health assembly and crossed the finish line,” Tedros said, reported The Straits Times. “But I remain confident that you still will, because where there is a will, there is a way.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Kennedy to cut 10,000 HHS employees to reduce ‘bureaucratic sprawl’

Published on

From The Center Square

By 

The changes are expected to reduce the agency’s headcount from 82,000 to 62,000 full-time employees.

Robert F. Kennedy Jr. announced a significant restructuring of the U.S. Department of Health and Human Services on Thursday in a move to streamline the huge federal agency and cut costs.

Kennedy plans to trim about 10,000 employees from the agency’s workforce in addition to employees who left as part of a Deferred Resignation Program, similar to a buy out, earlier this year. The move is expected to save about $1.8 billion.

Kennedy said the restructuring won’t affect the agency’s critical services. When combined with HHS’ other efforts, including early retirement, the changes are expected to reduce the agency’s headcount from 82,000 to 62,000 full-time employees. The restructuring will also align the department with Kennedy’s goals for a healthier U.S. population.

“We aren’t just reducing bureaucratic sprawl. We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic,” Kennedy said. “This Department will do more – a lot more – at a lower cost to the taxpayer.”

Kennedy also said the restructuring of the department’s 28 divisions will get rid of redundant units, consolidating them into “15 new divisions, including a new Administration for a Healthy America, or AHA, and will centralize core functions such as Human Resources, Information Technology, Procurement, External Affairs, and Policy.” Regional offices will be reduced from 10 to 5.

The overhaul will implement the new “HHS priority of ending America’s epidemic of chronic illness by focusing on safe, wholesome food, clean water, and the elimination of environmental toxins. These priorities will be reflected in the reorganization of HHS.”

Kennedy also said the restructuring would improve taxpayers’ experience with HHS by making the agency more responsive and efficient. He also said the changes would ensure that Medicare, Medicaid, and other essential health services remain intact.

The Administration for a Healthy America will combine multiple agencies – the Office of the Assistant Secretary for Health, Health Resources and Services Administration, Substance Abuse and Mental Health Services Administration, Agency for Toxic Substances and Disease Registry, and National Institute for Occupational Safety and Health — into a single, unified entity, Kennedy said.

The Centers for Disease Control and Prevention will get the Administration for Strategic Preparedness and Response, which is responsible for national disaster and public health emergency response.

“Over time, bureaucracies like HHS become wasteful and inefficient even when most of their staff are dedicated and competent civil servants,” Kennedy said. “This overhaul will be a win-win for taxpayers and for those that HHS serves.”

Among the cuts: The U.S. Food and Drug Administration will shed about 3,500 full-time employees. Officials said the reduction won’t affect drug, medical device, or food reviewers, nor will it impact inspectors. The CDC will drop about 2,400 employees. The National Institutes of Health will cut about 1,200 employees. The Centers for Medicare & Medicaid Services will cut about 300 employees. The reorganization won’t affect Medicare and Medicaid services, officials said.

Continue Reading

Health

How the once-blacklisted Dr. Jay Bhattacharya could help save healthcare

Published on

From LifeSiteNews

By Christina Maas

Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe.

Imagine spending your career studying infectious diseases, only to find that the real virus spreading uncontrollably is censorship. That was the reality for Dr. Jay Bhattacharya, a Stanford epidemiologist who committed the unpardonable sin of questioning the COVID-19 lockdown orthodoxy. His punishment? Digital exile, courtesy of Silicon Valley’s Ministry of Truth.

In December 2022, the Twitter Files exposed what many had long suspected: Twitter had quietly placed Bhattacharya’s account on a Trends Blacklist. This ensured that his posts, often critical of lockdowns and mask mandates, would never see the light of day on the platform’s trending topics. In other words, Twitter’s algorithm worked like a digital bouncer, making sure his dissenting opinions never made it past the velvet rope.

And Twitter wasn’t alone. Facebook, ever eager to please its government handlers, scrubbed the Great Barrington Declaration from its pages. That document, co-authored by Bhattacharya and other esteemed scientists, dared to suggest that maybe, just maybe, locking down entire populations wasn’t the best strategy. Instead, it proposed focused protection for the most vulnerable while allowing the rest of society to function. For this, it was sent to the digital equivalent of a gulag.

These experiences took center stage during Bhattacharya’s Senate confirmation hearing for the directorship of the National Institutes of Health (NIH). Republican lawmakers, who suddenly found themselves cast as the last defenders of free speech in scientific discourse, saw his nomination as a win.

During his testimony, Bhattacharya didn’t mince words. He detailed how the Biden administration played an active role in orchestrating the suppression of alternative views. It wasn’t enough for officials to push their own pandemic policies — they needed to ensure that no one, regardless of expertise, could challenge them in the public square.

The Science™ vs. The Science

Bhattacharya’s testimony laid bare an uncomfortable truth: the pandemic was a crisis of speech. “The root problem was that people who had alternative ideas were suppressed,” he told Sen. Ashley Moody (R-Fla.). “I personally was subject to censorship by the actions of the Biden administration during the pandemic.”

In a functioning society, that statement would spark bipartisan outrage. Instead, it barely registered. The people who spent years chanting “trust the science” were never interested in science at all.

Real science thrives on debate, skepticism, and the understanding that no single expert — no matter how credentialed—holds absolute truth. But during COVID, science became The Science™ — a government-approved doctrine enforced by Silicon Valley moderators and federal bureaucrats. Deviate from it, and you weren’t just wrong. You were dangerous.

A government-sanctioned muzzle

Bhattacharya wasn’t silenced in some haphazard, accidental way. The Biden administration actively leaned on social media companies to “moderate” voices like his. In practice, that meant tech executives — most of whom couldn’t tell a virus from a viral tweet — decided which epidemiologists the public was allowed to hear.

He responded with a lawsuit against the administration, accusing it of colluding with Big Tech to crush dissent. But in a ruling as predictable as it was revealing, the Supreme Court dismissed the case, arguing that Bhattacharya and his fellow plaintiffs lacked standing. Meaning: Yes, the government may have pressured private companies into silencing critics, but unless you can prove exactly how that harmed you, don’t expect the courts to care.

The real role of science

Despite everything, Bhattacharya didn’t argue for scientists to dictate policy. Unlike the public health bureaucrats who spent the pandemic issuing commandments from their Zoom thrones, he made it clear: “Science should be an engine for freedom,” he said. “Not something where it stands on top of society and says, ‘You must do this, this or this, or else.’”

That distinction matters. Science informs, but policy is about trade-offs. The problem wasn’t that officials got things wrong — it’s that they refused to admit the possibility. Instead of allowing open debate, they silenced critics. Instead of acknowledging uncertainty, they imposed rules with absolute certainty.

Bhattacharya wasn’t censored because he was wrong. He was censored because he questioned people who couldn’t afford to be.

His confirmation hearing made one thing clear: science wasn’t about data. It was about power. And in Washington, power doesn’t like to be questioned.

Science, money and power

At the heart of the hearing was a fundamental question: Who controls science that people are allowed to talk about? The NIH, with its $48 billion budget, is less a research institution and more a financial leviathan, shaping the direction of American science through the projects it funds (or doesn’t)  fund.

Bhattacharya’s nomination comes at a moment when the battle lines around scientific freedom, government intervention, and public trust in research are more entrenched than ever. The pandemic shattered the illusion that science was above politics. Instead, it exposed just how much political and corporate interests shape what counts as “settled” science.

The irony is thick enough to cut with a knife. The man once branded too dangerous for social media, blacklisted for questioning lockdowns, and effectively erased from mainstream discourse is now being handed a key role in the very government that tried to silence him. Dr. Jay Bhattacharya, once forced to the margins, is now at the center of power.

A new administration has decided that maybe — just maybe — silencing dissenting scientists wasn’t the best pandemic strategy. And in a twist no Hollywood scriptwriter would dare to pitch for being too on-the-nose, Bhattacharya wasn’t being welcomed back into the conversation — he’s being put in charge of it.

Bhattacharya was confirmed following a party-line vote Tuesday evening. The decision came after a similarly partisan endorsement from the Senate Committee on Health, Education, Labor and Pensions (HELP), clearing the final hurdle for President Donald Trump’s nominee.

Equally central to his testimony was Bhattacharya’s call for a sweeping shift in NIH priorities. He proposed a decentralization of research funding, stressing the need for greater inclusion of dissenting voices in the scientific process, an apparent rebuke of the consensus-driven culture that dominated during the pandemic. He emphasized targeting resources toward projects with a clear and measurable impact on public health, dismissing other NIH initiatives as “frivolous.”

Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe. His confirmation, hard-won and unapologetically political, is already shaking the scaffolding of a scientific establishment that long equated conformity with consensus.

Reprinted with permission from Reclaim The Net

Continue Reading

Trending

X